GW Pharma CEO on original cannabis-derived drug

GW Pharma CEO on original cannabis-derived drug

GW Pharmaceuticals CEO Justin Gover discusses how the firm secured FDA popularity of its cannabis-derived drug and what it says in regards to the future of cannabis-derived medication.

Trulieve CEO Kim Rivers on Q4 earnings and cannabis adult exhaust ballotin the U.S.

Trulieve CEO Kim Rivers on Q4 earnings and cannabis adult exhaust ballotin the U.S.

Kim Rivers, Trulieve CEO, founder, and chairwoman, joins ‘Like a flash Money’ to keep in touch quarterly results, cannabis on the ballot, user traits and further.

Aurora Cannabis CEO Terry Gross sales space to step down: RTRS

Aurora Cannabis CEO Terry Gross sales space to step down: RTRS

Aurora Cannabis CEO Terry Gross sales space is reportedly stepping down. CNBC’s Seema Mody has the principle points.

Contemporary Tilray CEO discusses building a world cannabis tag

Contemporary Tilray CEO discusses building a world cannabis tag

Tilray shareholders voted to approve the merger with Aphria. Contemporary Tilray CEO Irwin Simon joins ‘Closing Bell’ to keep in touch referring to the outlook of the cannabis tag. For…

Tilray CEO on Canada legalization, enhance and the cannabis trade

Tilray CEO on Canada legalization, enhance and the cannabis trade

Tilray CEO Brendan Kennedy sits down with CNBC’s ‘Declare on the Avenue’ personnel to talk about concerning the manner forward for his company and the cannabis trade after Canada legalized…

Aurora Cannabis CEO on ‘uneven’ Canadian gross sales

Aurora Cannabis CEO on ‘uneven’ Canadian gross sales

Miguel Martin, Aurora Cannabis CEO, joins ‘Energy Lunch’ to focus on the walk in gross sales the corporate is seeing in some system of Canada and what it may maybe…

LeafLink CEO Ryan Smith on cannabis market

LeafLink CEO Ryan Smith on cannabis market

LeafLink co-founder and CEO Ryan Smith joins “Relate Alley” to talk regarding the risk, pricing and viability of the cannabis market.

Cronos CEO on nicotine vaping versus cannabis vaping

Cronos CEO on nicotine vaping versus cannabis vaping

Cronos CEO Mike Gorenstein tells Jim Cramer what his company is doing diversified to enter the cannabis vaping condominium, in particular within the Canadian market.

GrowGeneration CEO seeks ‘extra tough’ cannabis licensing

GrowGeneration CEO seeks ‘extra tough’ cannabis licensing

GrowGeneration CEO and co-founder Darren Lampert joined CNBC’s Jim Cramer on Tuesday’s episode of “Inflamed Money,” explaining why he used to be optimistic on cannabis licensing across the East Flee….

Navy Capital CEO on Reddit investor interest in the cannabis stocks

Navy Capital is a firm that manages approximately $375 million in cannabis-related stocks. Sean Stiefel, Navy Capital CEO, joins ‘Closing Bell’ to discuss the recent increase in retail investor interest…